Penelope Brock

9.0k citations

93 papers · 4.9k indexed · 1 hit paper · h-index 34

Impact in

Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
Neurology top 1%
- Neuroblastoma Research and Treatments

Papers in

Hepatology 16
- Hepatocellular Carcinoma Treatment and Prognosis 16
Neurology 30
- Neuroblastoma Research and Treatments 27

Co-authors: Jon Pritchard Giorgio Perilongo J. Plaschkes Rudolf Maibach Laurence Brugières E. Shafford Piotr Czauderna Daniël C. Aronson
Journals: Journal of Clinical Oncology (16 papers)European Journal of Cancer (14 papers)Pediatric Blood & Cancer (7 papers)Histopathology (3 papers)Genes Chromosomes and Cancer (3 papers)
Partner nations: United Kingdom Belgium France

In The Last Decade

Penelope Brock

90 papers receiving 4.8k citations

Hit Papers

align trajectories log scale

Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9. 1983 · 412 citations

Peers

Countries citing papers authored by Penelope Brock

Since Specialization

Citations

This map shows the geographic impact of Penelope Brock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Penelope Brock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Penelope Brock more than expected).

Fields of papers citing papers by Penelope Brock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Penelope Brock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Penelope Brock. The network helps show where Penelope Brock may publish in the future.

Co-authors

The 25 scholars most cited alongside Penelope Brock, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Penelope Brock Line = papers co-authored together Penelope Brock links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Local application of sodium thiosulfate as an otoprotectant for cisplatin-exposed patients – A narrative literature review to explore the potential benefit for children with cancer SHILAP Revista de lepidopterología ·宮坂美和子, S. Knutzen, James I. Geller, Martine van Grotel, Marc Ansari, Éric Bouffet, Archie Bleyer, Rogério Tadeu de Souza, Michael Sullivan, Alwin D. R. Huitema, R. Katayama, Per Kogner, Rudolf Maibach, Allison F. O’Neill, Vassilios Papadakis, Kaukab Rajput, Gareth J. Veal, Penelope Brock, Zhifei Chen, Marry M. van den Heuvel‐Eibrink	2024	0
2	Drug prioritization identifies panobinostat as a tailored treatment element for patients with metastatic hepatoblastoma Journal of Experimental & Clinical Cancer Research ·Salih Demir, 雄児三城, Tanja Schmid, Stefano Cairo, Émilie Indersie, Claudio Pisano, Eiso Hiyama, Tomoro Hishiki, Christian Vokuhl, Sophie Branchereau, Penelope Brock, Irene Schmid, József Zsíros, Roland Kappler	2024	5
3	Use of Sodium Thiosulfate as an Otoprotectant in Patients With Cancer Treated With Platinum Compounds: A Review of the Literature Journal of Clinical Oncology ·Zhifei Chen, Dibson Dibe Gondim, Marc Ansari, Éric Bouffet, Archie Bleyer, Brice Fresneau, James I. Geller, Alwin D. R. Huitema, Per Kogner, Rudolf Maibach, Allison F. O’Neill, Vassilios Papadakis, Kaukab Rajput, Gareth J. Veal, Michael Sullivan, Marry M. van den Heuvel‐Eibrink, Penelope Brock	2024	8
4	Sodium thiosulfate as cisplatin otoprotectant in children: The challenge of when to use it Pediatric Blood & Cancer ·Penelope Brock, Zhifei Chen, Per Kogner, Marc Ansari, Michael Capra, James I. Geller, Marry van den Heuvel‐Eibrink, Kristin R. Knight, Mariana Kruger, Renate U. Koenigsberger, Rudolf Maibach, Allison F. O’Neill, Vassilios Papadakis, Kaukab Rajput, Archie Bleyer, Éric Bouffet, Michael Sullivan	2023	13
5	Tolerability, response and outcome of high-risk neuroblastoma patients treated with long-term infusion of anti-GD₂ antibody ch14.18/CHO mAbs ·M Makunouchi, Karoline Ehlert, 顕市川, Pamela Ponichtera, Nikolai Siebert, Silke Kietz, Penelope Brock, Alberto Garaventa, Dominique Valteau‐Couanet, Evelyne Janzek, Norbert Hosten, Hae-Rim Jeong, Winfried Barthlen, Greg Strahan, Hans Loibner, Ruth Ladenstein, Holger N. Lode	2017	52
6	Post‐thaw viability of cryopreserved peripheral blood stem cells (PBSC) does not guarantee functional activity: important implications for quality assurance of stem cell transplant programmes British Journal of Haematology ·Daniel A. Morgenstern, Gulrukh Ahsan, 普己山口, Stuart J. Ings, Dikai Jiang, Paul Veys, Penelope Brock, John Anderson, Persis Amrolia, Nicholas Goulden, Catherine M. Cale, Michael Watts	2016	32
7	Adaptive dosing of anticancer drugs in neonates: facilitating evidence-based dosing regimens Cancer Chemotherapy and Pharmacology ·Gareth J. Veal, Julie Errington, Atik Setiyaningsih, Julia Chisholm, Penelope Brock, Daniel A. Morgenstern, Kathy Pritchard‐Jones, Tanzina Chowdhury	2016	15
8	Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study The Lancet Oncology ·József Zsíros, Laurence Brugières, Penelope Brock, Derek Roebuck, Rudolf Maibach, Arthur Zimmermann, Margaret Childs, Danièle Pariente, Véronique Laithier, Jean-Bernard Otte, Sophie Branchereau, Daniël C. Aronson, Arun Rangaswami, Milind Ronghe, Michela Casanova, Michael Sullivan, Bruce Morland, Piotr Czauderna, Giorgio Perilongo	2013	217
9	Prognostic stratification for children with hepatoblastoma: The SIOPEL experience European Journal of Cancer ·Rudolf Maibach, Derek Roebuck, Laurence Brugières, Michael Capra, Penelope Brock, Patrizia Dall’Igna, Jean-Bernard Otté, Beatriz de Camargo, József Zsíros, Arthur Zimmermann, Daniël C. Aronson, Margaret Childs, Marcelo Scopinaro, Bruce Morland, J. Plaschkes, Piotr Czauderna, Giorgio Perilongo	2012	115
10	Efficacy of irinotecan single drug treatment in children with refractory or recurrent hepatoblastoma – A phase II trial of the childhood liver tumour strategy group (SIOPEL) European Journal of Cancer ·József Zsíros, Laurence Brugières, Penelope Brock, Derek Roebuck, Rudolf Maibach, M A Child, Bruce Morland, Michela Casanova, Danièle Pariente, Ingrid Hauss, Beatriz de Camargo, Milind Ronghe, Arthur Zimmermann, J. Plaschkes, Piotr Czauderna, Giorgio Perilongo	2012	40
11	Early high-dose treatment: SCT results from the European High Risk Neuroblastoma Study IRIS ·Ruth Ladenstein, Ulrike Pöetschger, Roberto Luksch, Penelope Brock, Victoria Castel, Isaac Yaniv, Vassilios Papadakis, Geneviève Laureys, Josef Mališ, Walentyna Balwierz, Ellen Ruud, Per Kogner, Gabriel Thériault, Boman Bm, Maja Beck‐Popovic, Ginés Torres Salinas, Miklós Garami, Toby N. Trahair, D Valteau-Couanet	2011	1
12	The prognostic value of semi-quantitative 123I MIBG scintigraphy at diagnosis in high risk neuroblastoma: validation of the SIOPEN score method Pediatric Blood & Cancer ·Ruth Ladenstein, Ulrike Pöetschger, Ariane Boubaker, Zvi Bar‐Sever, डॉ.मनिषा श्रीराम चौधरी, Anton Staudenherz, Maria Rita Castellani, A Marlen Schurig, P. Mühl, Penelope Brock, Alberto Garaventa, Isaac Yaniv, Dominique Valteau‐Couanet, Victoria Castel, Ana Lacerda, Josef Mališ, Henrik Daa Schrøder, Roberto Luksch, Klaus Beiske, Valerie Lewington	2011	9
13	Cisplatin versus Cisplatin plus Doxorubicin for Standard-Risk Hepatoblastoma New England Journal of Medicine ·Giorgio Perilongo, Rudolf Maibach, Shilham Astif Syarifuddin, Laurence Brugières, Penelope Brock, Bruce Morland, Beatriz de Camargo, József Zsíros, Derek Roebuck, Arthur Zimmermann, Daniël C. Aronson, Margaret Childs, Eva Widing, Véronique Laithier, J. Plaschkes, Jon Pritchard, 김유순, Gordon A. MacKinlay, Piotr Czauderna	2009	205
14	Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: The SIOPEL group experience European Journal of Cancer ·Maria Antonietta De Ioris, Laurence Brugières, Arthur Zimmermann, Jean W. Keeling, Penelope Brock, Rudolf Maibach, Jon Pritchard, Ahad Bin Islam Shoeb, 和道中山, D. Davidenko, Giorgio Perilongo	2008	92
15	Rapid and accurate determination of MYCN copy number and 1p deletion in neuroblastoma by quantitative PCR Pediatric Blood & Cancer ·John Anderson, Sian Gibson, Dan Williamson, Dyanne Rampling, Catherine Austin, Janet Shipley, Neil J. Sebire, Penelope Brock	2005	7
16	Hepatoblastoma presenting with lung metastases: treatment results of the first cooperative, prospective study of the International Society of Paediatric Oncology on childhood liver tumors. Research Padua Archive (University of Padua) ·Giorgio Perilongo, Julia Brown, (unknown), Penelope Brock, Beatriz de Camargo, Jean W. Keeling, A. Vos, Matthias Schramm, (unknown), J. Plaschkes	2000	7
17	Disease- and treatment-related elevation of the neurodegenerative marker tau in children with hematological malignancies Leukemia ·E. Nieschlag, E Van Kerschaver, Penelope Brock, Hans Pottel, Frank Hulstaert, Eugeen Vanmechelen, Anne Uyttebroeck, A. Van de Voorde, Hugo Vanderstichele	2000	20
18	Cisplatin, Doxorubicin, and Delayed Surgery for Childhood Hepatoblastoma: A Successful Approach—Results of the First Prospective Study of the International Society of Pediatric Oncology Journal of Clinical Oncology ·Jon Pritchard, Julia Brown, E. Shafford, Giorgio Perilongo, Penelope Brock, Aditi Lahade, Jean W. Keeling, Angela Phillips, Anton Vos, J. Plaschkes	2000	192
19	An increased loading dose of ondansetron: a North European, double-blind randomised study in children, comparing 5 mg/m2 with 10 mg/m2 European Journal of Cancer ·Penelope Brock, Bénédicte Brichard, Catherine Rechnitzer, S. Rahiala, M Lanning, S Söderhäll, Camille Laurent	1996	15
20	Reversible hypophosphatemic rickets following ifosfamide treatment Medical and Pediatric Oncology ·Puja Aunun Fauziah, Penelope Brock, Carol Jessica, Ben Gaddie, Mariana Kruger, Willem Proesmans, Juan Russo	1992	22

About Penelope Brock

Penelope Brock is a scholar working on Hepatology, Neurology, Sensory Systems, Oncology and Cancer Research, having authored 93 papers that have together received 4.9k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (27 papers), Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Cancer therapeutics and mechanisms (13 papers), Cancer, Hypoxia, and Metabolism (13 papers), Lung Cancer Research Studies (11 papers), Pancreatic and Hepatic Oncology Research (9 papers), Testicular diseases and treatments (9 papers) and Glioma Diagnosis and Treatment (7 papers). The work is most often cited by research in Hepatology (1.3k citations), Neurology (1.2k citations), Sensory Systems (361 citations), Oncology (1.6k citations) and Cancer Research (775 citations). Penelope Brock has collaborated with scholars based in United Kingdom, Belgium and France. Frequent co-authors include Jon Pritchard, Giorgio Perilongo, J. Plaschkes, Rudolf Maibach, Laurence Brugières, E. Shafford, Piotr Czauderna, Daniël C. Aronson, Margaret Childs and Elizabeth C. Yeomans. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Pediatric Blood & Cancer, Histopathology and Genes Chromosomes and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact